{"schema":"hottub-news/story/v1","story":"st_dxdxli64sedc4v3x4j2a","title":"Mirum posts phase 3 hepatitis win for 'commercially differentiated' challenger to Gilead, Vir","title_en":null,"outlets":1,"brief":null,"page":"https://hottub.news/stories/mirum-posts-phase-3-hepatitis-win-for-commercially-differentiated-dxdxli64se","count":1,"items":[{"id":"n_dxdxli64sedc4v3x4j2a","seq":462418,"kind":"article","title":"Mirum posts phase 3 hepatitis win for 'commercially differentiated' challenger to Gilead, Vir","url":"https://www.fiercebiotech.com/biotech/mirum-posts-phase-3-hepatitis-win-commercially-differentiated-challenger-gilead-and-vir","published":"2026-09-28T15:23:25Z","seen":"2026-09-28T15:23:25Z","lang":"en","source":{"id":"fiercebiotech.com","name":"fiercebiotech.com","domain":"fiercebiotech.com"},"via":"gdelt-gkg-english","topics":["economy","health"],"entities":[{"id":"Q922498","name":"Gilead","type":"org"}],"story":"st_dxdxli64sedc4v3x4j2a","category":"sport","category_p":0.4399999976158142,"sentiment":"positive","tone":-0.019999999552965164,"political":0.029999999329447746}]}